✦ LIBER ✦

Synthetic HDL as a new treatment for atherosclerosis regression: Has the time come?

✍ Scribed by Paola Conca; Guido Franceschini

Book ID: 116800189
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 261 KB
Volume: 18
Category: Article
ISSN: 0939-4753
DOI: 10.1016/j.numecd.2007.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: HDL Therapeutics fo

ChemInform Abstract: HDL Therapeutics for the Treatment of Atherosclerosis: A Brief Overview of the Synthetic Approaches.

✍ Manojit Pal 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 15 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

The Antiatherogenic Effect of DiNAC: Exp

The Antiatherogenic Effect of DiNAC: Experimental Findings Supporting Immunomodulation as a New Treatment for Atherosclerosis Related Diseases

✍ Pettersson, Knut ;Bergstrand, Håkan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

HIV-1 and intestinal helminth review upd

HIV-1 and intestinal helminth review update: Updating a Cochrane Review and building the case for treatment and has the time come to test and treat?

✍ P. E. ALEXANDER; P. DE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Has the time for first-line treatment wi

Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis

✍ Gurion, R.; Gafter-Gvili, A.; Vidal, L.; Leader, A.; Ram, R.; Shacham-Abulafia, 📂 Article 📅 2012 🏛 Ferrata Storti Foundation 🌐 Italian ⚖ 915 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views